People With Inflammatory Bowel Disease Face Barriers to Health Care
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 21, 2024 -- Patients with inflammatory bowel disease (IBD) continue to experience barriers to health care access and treatment and financial struggles, according to a study published online Oct. 8 in Inflammatory Bowel Diseases.
Ariel A. Jordan, M.D., from University of Michigan in Ann Arbor, and colleagues surveyed IBD patients and their caregivers (2,281 completed responses) regarding access to health care professionals, medications, and procedures; associated financial challenges; and patient awareness of education and advocacy tools to navigate IBD care barriers.
The researchers found that patients on advanced specialty medications, younger than 65 years of age, or on employer insurance experienced significantly greater issues with insurance barriers to accessing medications and coverage of medically necessary tests or treatments. Patients who live in areas of concentrated poverty were more likely to experience poor health outcomes as a result of step therapy versus patients who did not. Additionally, patients living in an area with concentrated poverty were more likely to experience one or more financial barriers or trade-offs if the patient used advanced specialty medicine.
"Ongoing awareness and advocacy efforts focused on health care system reform and related policies to further minimize care disparities and barriers remain vital," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-22 12:00
Read more
- Team Sports Score Big Points for Your Child's Brain, Study Finds
- 2019 to 2022 Saw Increase in E-Scooter/Bike-Related Injury ED Visits
- 1 in 3 Older Americans Say They Feel Lonely, Poll Finds
- FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
- U.S. Overdose Deaths Linked to Fentanyl May Be Declining
- Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions